Effects of canagliflozin on cardiac remodeling and hemodynamic parameters in patients with type 2 diabetes mellitus

Sodium-glucose cotransporter type 2 (SGLT2) inhibitors have demonstrated to reduce cardiovascular risk in patients with type 2 diabetes mellitus (T2DM) in large trials independent of glycemic control. The mechanisms of this cardioprotective property remain uncertain. Evidence suggests positive hemod...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Hsiao-Huai, Lai, Yau-Huei, Lin, Po-Lin, Chen, Hsin-Hao, Hung, Chung-Lieh, Liu, Lawrence Yu-Min, Yeh, Chih-Kuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694140/
https://www.ncbi.nlm.nih.gov/pubmed/38044371
http://dx.doi.org/10.1038/s41598-023-48716-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694140/
https://www.ncbi.nlm.nih.gov/pubmed/38044371
http://dx.doi.org/10.1038/s41598-023-48716-y

Ejemplares similares